---
layout: default
title: Aluminum Hydroxide
description: "Aluminum Hydroxide çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚ä¸­ç­‰è­‰æ“šç­‰ç´š L3ï¼ŒåŒ…å« 4 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: ä¸­è­‰æ“šç­‰ç´š (L3-L4)
nav_order: 19
evidence_level: L3
indication_count: 4
---

# Aluminum Hydroxide

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L3</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>4</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Aluminum Hydroxideï¼šå¾èƒƒé…¸éå¤šåˆ°æ´»å‹•æ€§æ¶ˆåŒ–æ€§æ½°ç˜

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Aluminum Hydroxide å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Aluminum hydroxide åŸæœ¬ç”¨æ–¼ç·©è§£èƒƒé…¸éå¤šåŠèƒƒéƒ¨ä¸é©ã€‚
TxGNN æ¨¡å‹é æ¸¬å®ƒå¯èƒ½å°**æ´»å‹•æ€§æ¶ˆåŒ–æ€§æ½°ç˜ (active peptic ulcer disease)** æœ‰æ•ˆï¼Œ
ç›®å‰æœ‰ **15 ç¯‡æ–‡ç»**æ”¯æŒé€™å€‹æ–¹å‘ã€‚
</p>


## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| åŸé©æ‡‰ç—‡ | èƒƒé…¸éå¤šã€èƒƒç‚ã€èƒƒåŠåäºŒæŒ‡è…¸æ½°ç˜ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | æ´»å‹•æ€§æ¶ˆåŒ–æ€§æ½°ç˜ (active peptic ulcer disease) |
| TxGNN é æ¸¬åˆ†æ•¸ | 99.64% |
| è­‰æ“šç­‰ç´š | L3 |
| å°ç£ä¸Šå¸‚ | æœ‰ä¸Šå¸‚ |
| è¨±å¯è­‰æ•¸ | å¤šå¼µï¼ˆå«è¤‡æ–¹è£½åŠ‘ï¼‰ |
| å»ºè­°æ±ºç­– | Proceed with Caution |


## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. active peptic ulcer disease</span>
<span class="evidence-badge evidence-L3">L3</span>
<span class="prediction-score">99.64%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content" markdown="1">

### ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ

Aluminum hydroxide æ˜¯ç¶“å…¸çš„åˆ¶é…¸åŠ‘ï¼Œé€éä¸­å’Œèƒƒé…¸ä¾†ä¿è­·èƒƒé»è†œã€‚å…¶ä½œç”¨æ©Ÿè½‰åŒ…æ‹¬ï¼š

1. **ä¸­å’Œèƒƒé…¸**ï¼šç›´æ¥ä¸­å’Œå·²åˆ†æ³Œçš„èƒƒé…¸ï¼Œæå‡èƒƒå…§ pH å€¼
2. **æŠ‘åˆ¶èƒƒè›‹ç™½é…¶æ´»æ€§**ï¼šåœ¨è¼ƒé«˜ pH ç’°å¢ƒä¸‹ï¼Œèƒƒè›‹ç™½é…¶æ´»æ€§é¡¯è‘—é™ä½
3. **é»è†œä¿è­·**ï¼šç ”ç©¶é¡¯ç¤ºå«é‹åˆ¶é…¸åŠ‘å…·æœ‰èƒƒé»è†œä¿è­·ä½œç”¨

å¾åŸé©æ‡‰ç—‡ï¼ˆèƒƒé…¸éå¤šã€èƒƒç‚ï¼‰åˆ°é æ¸¬é©æ‡‰ç—‡ï¼ˆæ´»å‹•æ€§æ¶ˆåŒ–æ€§æ½°ç˜ï¼‰ï¼Œ
æ©Ÿè½‰ä¸Šå…·æœ‰åˆç†é€£çµï¼Œçš†æ¶‰åŠèƒƒé…¸ä¸­å’Œèˆ‡é»è†œä¿è­·ã€‚

### è‡¨åºŠè©¦é©—

ç›®å‰ç„¡é‡å° Aluminum hydroxide å–®ç¨ç”¨æ–¼æ´»å‹•æ€§æ¶ˆåŒ–æ€§æ½°ç˜çš„è‡¨åºŠè©¦é©—ç™»è¨˜ã€‚

### ç›¸é—œæ–‡ç»

| PMID | å¹´ä»½ | é¡å‹ | æœŸåˆŠ | ä¸»è¦ç™¼ç¾ |
|------|-----|------|------|---------|
| [7034155](https://pubmed.ncbi.nlm.nih.gov/7034155/) | 1981 | RCT | Scand J Gastroenterol | åˆ¶é…¸åŠ‘/æŠ—è†½é¹¼è—¥ç‰©çµ„åˆåœ¨æ¶ˆåŒ–æ€§æ½°ç˜æ²»ç™‚ä¸­ï¼Œ6é€±ç™’åˆç‡é”96%ï¼Œèˆ‡ cimetidine ç›¸ç•¶ |
| [22950493](https://pubmed.ncbi.nlm.nih.gov/22950493/) | 2013 | Review | Curr Pharm Des | å«é‹åˆ¶é…¸åŠ‘å…·æœ‰è¶…è¶Šå‰åˆ—è…ºç´ çš„èƒƒé»è†œä¿è­·èˆ‡æ½°ç˜ç™’åˆä½œç”¨ |
| [1769429](https://pubmed.ncbi.nlm.nih.gov/1769429/) | 1991 | å‹•ç‰©ç ”ç©¶ | Digestion | Al(OH)3 å°æ€¥æ€§èƒƒé»è†œç—…è®Šå…·ä¿è­·ä½œç”¨ï¼Œä¸¦èƒ½ä¿ƒé€²æ…¢æ€§èƒƒåäºŒæŒ‡è…¸æ½°ç˜ç™’åˆ |
| [6086186](https://pubmed.ncbi.nlm.nih.gov/6086186/) | 1984 | Review | Clin Gastroenterol | åˆ¶é…¸åŠ‘èˆ‡æŠ—è†½é¹¼è—¥ç‰©åˆä½µæ²»ç™‚å¯ä¿ƒé€²åäºŒæŒ‡è…¸æ½°ç˜ç™’åˆ |
| [37146](https://pubmed.ncbi.nlm.nih.gov/37146/) | 1979 | Review | Fortschr Med | è¶³é‡åˆ¶é…¸åŠ‘å¯ä¿ƒé€²èƒƒæ½°ç˜åŠåäºŒæŒ‡è…¸æ½°ç˜åœ¨é–€è¨ºç—…æ‚£ä¸­ç™’åˆ |

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. gastroduodenitis</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.59%</span>
</summary>
<div class="indication-content" markdown="1">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.59%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. gastrojejunal ulcer</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.54%</span>
</summary>
<div class="indication-content" markdown="1">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.54%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. peptic ulcer perforation</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.54%</span>
</summary>
<div class="indication-content" markdown="1">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.54%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

| è¨±å¯è­‰è™Ÿ | å“å | åŠ‘å‹ | æ ¸å‡†é©æ‡‰ç—‡ |
|---------|------|------|-----------|
| å…§è¡›è—¥è£½å­—ç¬¬000373è™Ÿ | å›ºèƒƒå¿…æœ—éŒ  | éŒ åŠ‘ | èƒƒã€åäºŒæŒ‡è…¸æ½°ç˜ã€èƒƒé…¸éå¤šç—‡ã€èƒƒç‚ã€èƒƒç—› |
| å…§è¡›è—¥è£½å­—ç¬¬006937è™Ÿ | æ°«æ°§åŒ–é‹è†  | ç²‰åŠ‘ | åˆ¶é…¸åŠ‘ |

å‚™è¨»ï¼šå¤šæ•¸å« Aluminum hydroxide çš„è£½åŠ‘ç‚ºè¤‡æ–¹è£½åŠ‘ã€‚

## å®‰å…¨æ€§è€ƒé‡

- **è—¥ç‰©äº¤äº’ä½œç”¨**ï¼š
  - **é‡å¤§äº¤äº’ä½œç”¨**ï¼šèˆ‡ Dolutegravirï¼ˆæŠ—HIVè—¥ç‰©ï¼‰ä½µç”¨æœƒé™ä½å…¶å¸æ”¶
  - **ä¸­åº¦äº¤äº’ä½œç”¨**ï¼šèˆ‡ Acalabrutinib ä½µç”¨éœ€æ³¨æ„
  - **è¼•å¾®äº¤äº’ä½œç”¨**ï¼šèˆ‡ Famotidineã€Ranitidineã€Acebutolol ç­‰
- **é•·æœŸä½¿ç”¨æ³¨æ„äº‹é …**ï¼šé•·æœŸå¤§é‡ä½¿ç”¨å¯èƒ½å°è‡´é‹è“„ç©ï¼Œå°¤å…¶åœ¨è…åŠŸèƒ½ä¸å…¨æ‚£è€…

### è—¥ç‰©-é£Ÿç‰©äº¤äº’ä½œç”¨ (DFI)

<div class="dfi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a></div>

**æŸ‘æ©˜é¡æ°´æœ (citrus fruits)** ğŸŸ¢ Minor
- å½±éŸ¿ï¼šThe concomitant administration of aluminum-containing products (e.g., antacids and phosphate binders) and citrates may significantly increase serum aluminum concentrations, resulting in toxicity.  Cit...
- å»ºè­°ï¼šSome experts recommend that antacids should not be mixed with or given after high protein formulations, that the antacid dose should be separated from the feeding by as much as possible, and that the ...

**æ±½æ°´/ç¢³é…¸é£²æ–™ (soft drinks)** ğŸŸ¢ Minor
- å½±éŸ¿ï¼šThe concomitant administration of aluminum-containing products (e.g., antacids and phosphate binders) and citrates may significantly increase serum aluminum concentrations, resulting in toxicity.  Cit...
- å»ºè­°ï¼šSome experts recommend that antacids should not be mixed with or given after high protein formulations, that the antacid dose should be separated from the feeding by as much as possible, and that the ...



### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a></div>

**Constipation** ğŸŸ¢ Minor
- Aluminum containing antacids may produce constipation, which may lead to intestinal obstruction.  Osteomalacia and hypophosphatemia may be produced in patients with renal dysfunction who are not receiving dialysis.  Patients with renal dysfunction, i...

## çµè«–èˆ‡ä¸‹ä¸€æ­¥

**æ±ºç­–ï¼šProceed with Caution**

**ç†ç”±ï¼š**
Aluminum hydroxide ä½œç‚ºåˆ¶é…¸åŠ‘ç”¨æ–¼æ¶ˆåŒ–æ€§æ½°ç˜æœ‰æ­·å²æ–‡ç»æ”¯æŒï¼Œä½†ç¾ä»£æ²»ç™‚å·²æœ‰æ›´æœ‰æ•ˆçš„é¸æ“‡ï¼ˆå¦‚ PPIã€H2 é˜»æ–·åŠ‘ï¼‰ã€‚é æ¸¬é©æ‡‰ç—‡èˆ‡åŸé©æ‡‰ç—‡é‡ç–Šåº¦é«˜ï¼Œå¯è¦–ç‚ºåŸé©æ‡‰ç—‡çš„å»¶ä¼¸è€ŒéçœŸæ­£çš„è€è—¥æ–°ç”¨ã€‚

**è‹¥è¦æ¨é€²éœ€è¦ï¼š**
- èˆ‡ç¾ä»£æ¨™æº–æ²»ç™‚çš„æ¯”è¼ƒæ€§ç ”ç©¶
- æ˜ç¢ºçš„çµ¦è—¥åŠ‘é‡èˆ‡ç™‚ç¨‹å»ºè­°
- é•·æœŸå®‰å…¨æ€§ï¼ˆç‰¹åˆ¥æ˜¯é‹è“„ç©ï¼‰çš„è©•ä¼°


---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Dupilumab]({{ "/drugs/dupilumab/" | relative_url }}) - è­‰æ“šç­‰ç´š L3
- [Human Immunoglobulin G]({{ "/drugs/human_immunoglobulin_g/" | relative_url }}) - è­‰æ“šç­‰ç´š L3
- [Lornoxicam]({{ "/drugs/lornoxicam/" | relative_url }}) - è­‰æ“šç­‰ç´š L3
- [Inositol]({{ "/drugs/inositol/" | relative_url }}) - è­‰æ“šç­‰ç´š L3
- [Dorzolamide]({{ "/drugs/dorzolamide/" | relative_url }}) - è­‰æ“šç­‰ç´š L3

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Aluminum Hydroxideè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/aluminum_hydroxide/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_aluminum_hydroxide,
  title = {Aluminum Hydroxideè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/aluminum_hydroxide/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
